PHOTOSOUND TECHNOLOGIES, INC.

Medtech · Private

Photoacoustic tomography imaging instrument for three-dimensional functional and molecular imaging of small animal models

Grants
$2.5M
5 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$65K
1 award · Health and Human S
#557 of 4531 in medtech
Patents
8
3 granted · 5 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Integrated photoacoustic and fluorescence imaging system for anatomical, functional, and molecular characterization of murine models$211,480
Federal grantDepartment of Health and Human Services · Phase I · Preclinical small animal imaging platform for detection and quantification of early metastasis$279,143
Federal grantDepartment of Health and Human Services · Phase I · Preclinical small animal imaging platform for detection and quantification of early metastasis$55,000
Federal grantDepartment of Health and Human Services · Phase II · Integrated photoacoustic and fluorescence imaging system for anatomical, functional, and molecular characterization of murine models$997,451
Federal grantDepartment of Health and Human Services · Phase II · Integrated photoacoustic and fluorescence imaging system for anatomical, functional, and molecular characterization of murine models$926,753
Federal contractDepartment of Health and Human Services · Daq Platform With Handheld Linear Array Trans$65,309
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
554Quantum Surgical Inc$67K$68M
555KAER BIOTHERAPEUTICS CORPORATION$66K—
556PLENOPTIKA, INC.$65K$50K
557PHOTOSOUND TECHNOLOGIES, INC.$65K—
558DAKTARI DIAGNOSTICS, INC.$63K$34M
559Global Cooling, Inc.$61K$3.2M
560Cytocybernetics$61K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 3 granted of 8

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.